The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pneumonia Vaccine Market Research Report 2025

Global Pneumonia Vaccine Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1426287

No of Pages : 90

Ask Your Query

Synopsis

Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.

The global Pneumonia Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Pneumonia Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumonia Vaccine.

Report Scope

The Pneumonia Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pneumonia Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pneumonia Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Pfizer Inc.
  • Glaxosmithkline Plc.
  • Merck & Co., Inc.
  • Sanofi Pasteur
  • Serum Institute of India Pvt. Ltd.
  • Johnson & Johnson
  • Astellas Pharma Inc.
  • Astrazeneca Plc.
  • CSL Limited
  • Emergent Biosolutions
  • Walvax Biotechnology
  • Royal (Wuxi) Bio-Pharmaceutical
  • Zhifei Biologic

Segment by Type

  • Pneumococcal Conjugate Vaccine (PCV13)
  • Pneumococcal Polysaccharide Vaccine (PPSV23)
  • Other

Segment by Application

  • Pneumonia
  • Meningitis
  • Sepsis

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pneumonia Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pneumonia Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Pneumonia Vaccine Market Overview
1.1 Product Overview and Scope of Pneumonia Vaccine
1.2 Pneumonia Vaccine Segment by Type
1.2.1 Global Pneumonia Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.2.4 Other
1.3 Pneumonia Vaccine Segment by Application
1.3.1 Global Pneumonia Vaccine Market Value by Application: (2024-2030)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Sepsis
1.4 Global Pneumonia Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumonia Vaccine Revenue 2019-2030
1.4.2 Global Pneumonia Vaccine Sales 2019-2030
1.4.3 Global Pneumonia Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pneumonia Vaccine Market Competition by Manufacturers
2.1 Global Pneumonia Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pneumonia Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pneumonia Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Pneumonia Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumonia Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumonia Vaccine, Product Type & Application
2.7 Pneumonia Vaccine Market Competitive Situation and Trends
2.7.1 Pneumonia Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pneumonia Vaccine Players Market Share by Revenue
2.7.3 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pneumonia Vaccine Retrospective Market Scenario by Region
3.1 Global Pneumonia Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pneumonia Vaccine Global Pneumonia Vaccine Sales by Region: 2019-2030
3.2.1 Global Pneumonia Vaccine Sales by Region: 2019-2024
3.2.2 Global Pneumonia Vaccine Sales by Region: 2025-2030
3.3 Global Pneumonia Vaccine Global Pneumonia Vaccine Revenue by Region: 2019-2030
3.3.1 Global Pneumonia Vaccine Revenue by Region: 2019-2024
3.3.2 Global Pneumonia Vaccine Revenue by Region: 2025-2030
3.4 North America Pneumonia Vaccine Market Facts & Figures by Country
3.4.1 North America Pneumonia Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pneumonia Vaccine Sales by Country (2019-2030)
3.4.3 North America Pneumonia Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pneumonia Vaccine Market Facts & Figures by Country
3.5.1 Europe Pneumonia Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pneumonia Vaccine Sales by Country (2019-2030)
3.5.3 Europe Pneumonia Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumonia Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Pneumonia Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pneumonia Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Pneumonia Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pneumonia Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pneumonia Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pneumonia Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Pneumonia Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumonia Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pneumonia Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pneumonia Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pneumonia Vaccine Sales by Type (2019-2030)
4.1.1 Global Pneumonia Vaccine Sales by Type (2019-2024)
4.1.2 Global Pneumonia Vaccine Sales by Type (2025-2030)
4.1.3 Global Pneumonia Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pneumonia Vaccine Revenue by Type (2019-2030)
4.2.1 Global Pneumonia Vaccine Revenue by Type (2019-2024)
4.2.2 Global Pneumonia Vaccine Revenue by Type (2025-2030)
4.2.3 Global Pneumonia Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pneumonia Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pneumonia Vaccine Sales by Application (2019-2030)
5.1.1 Global Pneumonia Vaccine Sales by Application (2019-2024)
5.1.2 Global Pneumonia Vaccine Sales by Application (2025-2030)
5.1.3 Global Pneumonia Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Pneumonia Vaccine Revenue by Application (2019-2030)
5.2.1 Global Pneumonia Vaccine Revenue by Application (2019-2024)
5.2.2 Global Pneumonia Vaccine Revenue by Application (2025-2030)
5.2.3 Global Pneumonia Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Pneumonia Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Inc. Pneumonia Vaccine Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Glaxosmithkline Plc.
6.2.1 Glaxosmithkline Plc. Corporation Information
6.2.2 Glaxosmithkline Plc. Description and Business Overview
6.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Product Portfolio
6.2.5 Glaxosmithkline Plc. Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Corporation Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co., Inc. Pneumonia Vaccine Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sanofi Pasteur Pneumonia Vaccine Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 Serum Institute of India Pvt. Ltd.
6.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
6.5.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Portfolio
6.5.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Johnson & Johnson Pneumonia Vaccine Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Astellas Pharma Inc.
6.6.1 Astellas Pharma Inc. Corporation Information
6.6.2 Astellas Pharma Inc. Description and Business Overview
6.6.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Astellas Pharma Inc. Pneumonia Vaccine Product Portfolio
6.7.5 Astellas Pharma Inc. Recent Developments/Updates
6.8 Astrazeneca Plc.
6.8.1 Astrazeneca Plc. Corporation Information
6.8.2 Astrazeneca Plc. Description and Business Overview
6.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Astrazeneca Plc. Pneumonia Vaccine Product Portfolio
6.8.5 Astrazeneca Plc. Recent Developments/Updates
6.9 CSL Limited
6.9.1 CSL Limited Corporation Information
6.9.2 CSL Limited Description and Business Overview
6.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CSL Limited Pneumonia Vaccine Product Portfolio
6.9.5 CSL Limited Recent Developments/Updates
6.10 Emergent Biosolutions
6.10.1 Emergent Biosolutions Corporation Information
6.10.2 Emergent Biosolutions Description and Business Overview
6.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Emergent Biosolutions Pneumonia Vaccine Product Portfolio
6.10.5 Emergent Biosolutions Recent Developments/Updates
6.11 Walvax Biotechnology
6.11.1 Walvax Biotechnology Corporation Information
6.11.2 Walvax Biotechnology Pneumonia Vaccine Description and Business Overview
6.11.3 Walvax Biotechnology Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Walvax Biotechnology Pneumonia Vaccine Product Portfolio
6.11.5 Walvax Biotechnology Recent Developments/Updates
6.12 Royal (Wuxi) Bio-Pharmaceutical
6.12.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
6.12.2 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Description and Business Overview
6.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Portfolio
6.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
6.13 Zhifei Biologic
6.13.1 Zhifei Biologic Corporation Information
6.13.2 Zhifei Biologic Pneumonia Vaccine Description and Business Overview
6.13.3 Zhifei Biologic Pneumonia Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Zhifei Biologic Pneumonia Vaccine Product Portfolio
6.13.5 Zhifei Biologic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumonia Vaccine Industry Chain Analysis
7.2 Pneumonia Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumonia Vaccine Production Mode & Process
7.4 Pneumonia Vaccine Sales and Marketing
7.4.1 Pneumonia Vaccine Sales Channels
7.4.2 Pneumonia Vaccine Distributors
7.5 Pneumonia Vaccine Customers
8 Pneumonia Vaccine Market Dynamics
8.1 Pneumonia Vaccine Industry Trends
8.2 Pneumonia Vaccine Market Drivers
8.3 Pneumonia Vaccine Market Challenges
8.4 Pneumonia Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock